Compare Supplements

There is no established or legitimate human dose. IDRA-21 is a grey-market 'research chemical' AMPAKINE with NO human clinical trials, no approval, and no pharmacovigilance — this library does NOT provide a dosing protocol. The only quantitative figures come from animal work: oral IDRA-21 at roughly 3-5.6 mg/kg reversed a learning deficit in patas monkeys (Thompson 1995) and racemic IDRA-21 enhanced rat water-maze performance — animal research doses that are NOT human recommendations and cannot be scaled to people. Vendor and forum figures are unverified extrapolations for a product of unknown identity and purity, taken without medical supervision or seizure monitoring.

Morning

No human form is endorsed — IDRA-21 is an unstudied-in-humans 'research chemical' ampakine with no approved or supplement form

• Any human use — IDRA-21 is an UNSTUDIED-IN-HUMANS grey-market 'research chemical' with no human clinical trials, no approval, and product of unverified identity, purity and dose; it is NOT a dietary supplement and NOT an approved medicine
• Anyone seeking it as a memory / cognition 'nootropic' — the benefit is shown only in rodents and monkeys and is UNPROVEN in humans, against a theoretical excitotoxicity/seizure risk
• Anyone with epilepsy, a seizure history, or a lowered seizure threshold — potentiating AMPA/glutamate transmission can theoretically provoke seizures

• Pro-convulsant / seizure-threshold-lowering drugs (e.g. bupropion, tramadol, some antipsychotics, fluoroquinolones)
• Other glutamatergic / nootropic 'racetam' or ampakine compounds
• Stimulants / caffeine and other CNS-active drugs